Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed Tacrolimus to Sirolimus Conversion in Renal Transplant
NCT00931255Phase 4Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Apr 2009
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in kidney transplant rejection (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Composite Endpoint of Reduction of eGFR >15% & Progression in Fibrosis Score >=20% at 1 year. Started Apr 2009; status: terminated.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00931255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931255.